ID   Ku812E
AC   CVCL_0615
SY   KU812E; KU-812E; KU 812E
DR   CLO; CLO_0007126
DR   CLO; CLO_0051000
DR   CLDB; cl3071
DR   ATCC; CRL-2100
DR   BioSample; SAMN01821694
DR   cancercelllines; CVCL_0615
DR   CCRID; 1102HUM-NIFDC00110
DR   ECACC; 90071803
DR   JCRB; JCRB0104.1
DR   LINCS_LDP; LCL-1107
DR   RCB; RCB0496
DR   Wikidata; Q54900695
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=2540861;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Lys132Arg (c.395A>G); ClinVar=VCV000376625; Zygosity=Homozygous (from parent cell line).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
CC   Cell type: Basophil progenitor cell; CL=CL_0000613.
ST   Source(s): ATCC; CCRID; JCRB; RCB
ST   Amelogenin: X,Y
ST   CSF1PO: 12,13
ST   D13S317: 8
ST   D16S539: 9
ST   D18S51: 13
ST   D21S11: 30,31.2
ST   D3S1358: 15
ST   D5S818: 10
ST   D7S820: 12
ST   D8S1179: 11,15
ST   FGA: 22,24
ST   Penta D: 12
ST   Penta E: 5,19
ST   TH01: 9
ST   TPOX: 12
ST   vWA: 15
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0379 ! Ku812
SX   Male
AG   38Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 05-10-23; Version: 25
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In) ISBN 9780122219702; pp.1-733; Academic Press; London (2001).
//
RX   PubMed=2540861; DOI=10.1182/blood.V73.7.2003.2003;
RA   Nakazawa M., Mitjavila-Garcia M.-T., Debili N., Casadevall N.,
RA   Mayeux P., Rouyer-Fessard P., Dubart-Kupperschmitt A., Romeo P.-H.,
RA   Beuzard Y., Kishi K., Breton-Gorius J., Vainchenker W.;
RT   "KU 812: a pluripotent human cell line with spontaneous erythroid
RT   terminal maturation.";
RL   Blood 73:2003-2013(1989).
//